End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.12 CNY | +0.20% | +2.79% | -35.69% |
04-26 | Walvax Biotechnology's Profit Drops 92%, Operating Income Slids 28% in Q1 2024 | MT |
04-25 | Walvax Biotechnology's Unit to End COVID-19 Vaccine Trial | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.69% | 3.35B | |
-3.62% | 88.91B | |
+4.08% | 41.25B | |
-15.09% | 31.99B | |
+53.68% | 24.73B | |
-15.13% | 15.54B | |
-8.63% | 12.05B | |
-40.39% | 12.07B | |
+6.22% | 8.84B | |
-5.73% | 8.3B |
- Stock Market
- Equities
- 300142 Stock
- News Walvax Biotechnology Co., Ltd.
- Walvax Biotechnology Sees Up to 45% Drop in 2023 Profit